Discover 3,064 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,064
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Criterium, Inc.
Sex: All
Age: 18+
Code: NCT06992258
Phase2, Recruiting
Integrating Brain, Neurocognitive, and Computational Tools in OUD
for
Opioid Use Disorder
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 60
Code: NCT06136247
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Lebanon NH,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase3, Recruiting
Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer
for
Head and Neck Carcinoma
Location: Pittsburgh PA
Sponsor: Yvonne Mowery
Sex: All
Age: 18+
Code: NCT07227792
Recruiting
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Hackensack NJ, Richmond VA, Pittsburgh PA, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06980038
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
SNV4818 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, Philadelphia PA, Ottawa, Toronto,
Sponsor: Pikavation Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06736704
Phase1, Phase2, Recruiting
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Charlottesville VA, Pittsburgh PA, Wesley Chapel FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07012031
Phase1, Phase2, Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
for
Primary Immunoglobulin A Nephropathy (IgAN)
Location: Philadelphia PA, Gainesville FL, Aurora CO,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 18
Code: NCT06994845
Phase3, Recruiting
A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Ottawa, Erie PA
Sponsor: Kriya Therapeutics, Inc.
Sex: All
Age: 55 - 70+
Code: NCT06765980
Phase1, Phase2, Recruiting
EVR and EPO for Liver Transplant Tolerance
for
Liver Transplant
Location: Philadelphia PA, Chicago IL, San Francisco CA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06832189
Phase1, Recruiting
PUSH-IT Continuing Enteral Feeds for Tracheostomy
for
Tracheostomy Complication, Critical Illness,
Location: Danbury CT, Allentown PA, West Palm Beach FL,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 18+
Code: NCT05906472
Recruiting
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
for
Connective Tissue Diseases
Location: New York NY, Philadelphia PA, Los Angeles CA
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06716606
Phase3, Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
for
Peripheral Arterial Disease
Location: Levis, Laval, Virginia Beach VA, Bowie MD, Camp Hill PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07223593
Phase3, Recruiting
Clinical Trial to Reduce Perinatal Intimate Partner Violence
for
Domestic Violence, Perinatal Problems
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: Female
Age: 18+
Code: NCT07165860
Recruiting
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
for
Sickle Cell Disease
Location: New York NY, Greenville NC, Durham NC, Pittsburgh PA,
Sponsor: Disc Medicine, Inc
Sex: All
Age: 18+
Code: NCT07187973
Phase1, Recruiting
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)